Nestlé has launched a new proprietary blend for infant nutrition combining a probiotic strain with varying levels of six human milk oligosaccharides (HMOs) to support the developing infant through its life stages.
The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.
As the race to create infant formula ever closer in composition to human breast milk gathers pace, Berkeley-based infant nutrition startup NAMUH and synthetic biology specialist Ginkgo Bioworks have teamed up to develop human milk oligosaccharides (HMOs)...
Individual human milk oligosaccharides (HMOs) may play critical roles in the maturation of gray matter in an infant brain, showing that inclusion of specific HMOs in infant formula could be beneficial, says a new study.
